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Chapter 7 
THE APPLICATION OF DNA MICROARRAYS 
IN THE FUNCTIONAL GENOMIC STUDY OF 
SCHISTOSOME/HOST BIOLOGY 
Karl F. Hoffman and Jennifer M. Fitzpatrick 
Department of Pathology, University of Cambridge, Tennis Court Road, CB2 1QP, UK 
Key words:   
1. INTRODUCTION 
The end of the 20th century and the start of the new millennium have 
bore witness to a remarkable revolution in the way parasite/host biological 
interactions can be conceptually designed and experimentally studied.  
Although most traditional investigations of parasitism have been motivated 
by hypothesis- or model-driven science, the recent successes of parasite and 
host expressed sequence tag (EST)/genomic sequencing projects have 
opened up a new avenue to the parasitologist – discovery driven science.  
Even the most steadfast, classically-trained parasitologist can see enormous 
value in coupling conventional experimental techniques with the new and 
exciting technologies made possible by genome sequencing efforts.  In this 
era of functional genomics (defined as experimental approaches that use 
genomic structural information to understand biology in a systemic and 
comprehensive fashion (1)) the genome-wide analysis of mRNA expression 
using DNA microarrays has become pivotal.  Here, we review the impact 
DNA microarrays have had on recent schistosome/host investigations and 
outline the exciting future areas we plan to visit in our study of schistosome 
sexual maturation, developmental biology, gender interactions, and host 
immuno-biology. 
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2. DNA MICROARRAYS  
Use of glass slide DNA microarrays to study transcriptional changes 
between two different nucleic acid samples obtained from eukaryotes was 
first reported in 1995-1996, when Patrick Brown’s group at Stanford 
University published a series of seminal observations on Arabidopsis and 
Saccharomyces gene expression (2, 3). These high profile investigations 
brought DNA microarray technology worldwide publicity, building on the 
principles first conceived by Ekins and Chu during their development of 
solid-support immunoassays in the 1980’s (4).  DNA microarray technology 
has exploded since these early reports of its usage and all aspects of this 
evolving functional genomics tool have recently been critically re-reviewed 
in Nature Genetics (Supplement Volume 32, 2002).   
A major advantage of utilizing DNA microarrays to study gene 
expression in the functional genomics era is that current technological 
improvements in robotics have made it possible to systematically array 
thousands of DNA elements onto chemically defined matrixes.  In some 
cases, whole genomes of pathogenic organisms can be represented on a 
single glass slide (5).  This means that gene expression profiles of whole 
genomes can be assayed simultaneously, exponentially increasing the 
amount of biological information obtained every time a single experiment is 
performed.  However, highly informative DNA microarray studies have 
already been performed on partial parasite genomes (eg. Plasmodium (6)); 
this will continue to be the trend especially for those parasite species where 
complete genome annotation is unlikely in the near future (eg. Ascaris, 
Echinococcus, and Trichuris).  
The vast amounts of sequence information available  for mouse and man 
has made DNA microarrays from these schistosome definitive hosts an 
additional attractive resource for numerous questions related to parasite/host 
interactions.  These questions might include how immunopathology 
develops, how immune responses are induced and regulated during infection, 
and what immune correlates are associated with resistance and vaccine 
induced protection.  Together, the combined use of schistosome and host 
DNA microarrays in modern parasitological experimentation will be 
instrumental in generating comprehensive views of the mechanisms 
influencing host/parasite immuno-biology.   
Two of our recent studies utilizing DNA microarrays have provided 
insight into the immunopathology of murine schistosomiasis (7) as well as 
the sexual dichotomy of adult parasites (8).  As these two studies provided 
the framework for our continued interest in using DNA microarrays for 
future investigations into schistosome biology, they will be discussed below 
with attention given to the major findings included in each investigation. 
DNA microarrays for schistosome/host biology 3
 
 
3. STUDYING EGG-INDUCED IMMUNO-
PATHOLOGY IN MURINE SCHISTOSOMIASIS 
USING cDNA MICROARRAYS 
The schistosome egg is the causative agent that precipitates most severe 
forms of immuno-pathology in the murine model of schistosomiasis (see 
chapters 8 and 9).  Distinct forms of clinical disease exist in the mouse 
model and these differences are attributable to the specific type of immune 
reactions developing in response to schistosome eggs (recently reviewed 
(9)).  For example, schistosome-infected interleukin 10 (IL-10)/IL-12 (type-
2 polarized) and IL-10/IL-4 (type-1 polarized) – deficient mice display 
distinct, and non-overlapping egg-induced pathologies, yet both groups of 
animals suffer from elevated mortality rates (10) in comparison to infected 
WT (wild-type) mice.  Type-1 polarized animals display 100% mortality at 8 
weeks post-infection and exhibit elevated splenic iNOS activity, increased 
production of pro-inflammatory cytokines (found in both liver and serum), 
decreased hepatic fibrosis, increased levels in circulating liver transaminase, 
and rapid cachexia.  In contrast, the type-2 polarized animals develop a 
progressive wasting disease that correlates with increased production of the 
pro-fibrotic cytokines IL-4 and IL-13, augmented hepatic fibrosis, and 
significant mortality (~ 50%) during the chronic stages of infection.  For 
greater insight into the genetic differences associating with these diverse 
egg-induced pathologies, a murine cDNA microarray fabricated from 2200 
unique DNA elements was used to obtain gene expression profiles from 
hepatic tissue harvested from both infected mouse strains (7).  Profiles 
obtained for the infected type-1 polarized mice illustrate that aberrant 
regulation of the apoptotic machinery, increased recruitment of activated 
macrophages and neutrophils, and diminished ability to transcribe genes 
associated with collagen production are likely contributing to the egg-
induced hepatic pathology.  In contrast, hepatic transcriptional analysis of 
the infected type-2 polarized animals clearly demonstrate that genes 
involved in wound repair, extra-cellular matrix remodeling, and collagen 
deposition are induced to a much greater degree than observed for the type-1 
polarized mice.  These findings thus provided a further mechanistic 
explanation for the increased mortality rates in type-2 polarized mice and 
illustrate that type-2 responses promote and type-1 responses inhibit gene 
transcriptional pathways associated with liver collagen synthesis and matrix 
remodeling.  Furthermore, this study produced a list of candidate genes 
involved in egg-induced pathology and details how gene expression profiles 
can lead to insight (role of apoptosis, activated neutrophils and 
macrophages) into previously unappreciated disease mechanisms that 
contribute to pathogenesis during infection with schistosomes. 
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4. STUDYING SCHISTOSOME SEXUAL 
MATURATION USING cDNA MICROARRAYS 
Shortly after the above immuno-pathological study, we became interested 
in using DNA microarrays to examine schistosome sexual maturation and 
developmental biology.  The two experimental disciplines are logically 
linked, as murine pathology can be directly related to the biology of parasite 
sexual maturation.  Specifically, adult male schistosomes induce sexual 
maturation in females (11), which leads to the production of the 100-300 
eggs/worm pair every day during infection with this trematode.  Any 
additional information relating to the processes regulating or associating 
with schistosome sexual maturation and development can be instrumental in 
understanding, and eventually controlling the immuno-pathology of disease.  
In a preliminary experiment aimed at identifying novel sex-associated gene 
transcripts, we fabricated a small S. mansoni cDNA microarray from three 
cDNA libraries originating from two different parasite developmental stages 
and probed these DNA microarrays with sexually mature male and female 
material (8).  Although the fabricated cDNA microarray consisted of less 
than 10% of the predicted ORF content of the S. mansoni genome, this study 
expanded the list of gender-associated gene transcripts from all previous 
studies by a factor of two and provided novel research avenues towards our 
understanding of the molecules involved in egg-production, tegumental 
biology, and other sex-related biological processes.  We, and others, are in 
the process of functionally characterizing the biological importance of many 
of these differentially expressed transcripts.   
Due to this pilot experiment’s success, we have recently begun the 
fabrication of an expanded S. mansoni oligonucleotide DNA microarray (Fig 
1, panel I - containing ~ 50% of the predicted ORF genome content) as well 
as a small S. japonicum cDNA microarray (Fig 1, panel V - 456 unique 
cDNA clones or ~ 3% of the predicted ORF genome content).  These two 
resources will be extensively used over the next several years to aid our 
functional genomic research of schistosome biology (discussed in greater 
detail below).  
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Figure 7-1. Schistosome specific DNA microarrays that will be used in future functional 
genomic studies of host-schistosome interactions. (S. mansoni oligonucleotide DNA 
microarrays containing 7500 unique elements (I) and S. japonicum cDNA microarrays 
containing 456 unique elements (V)) will be used to identify transcripts associated with: (II) 
sexual maturation, (III) developmental expression, and (IV) immuno-pathology.  (II) An 
example of one planned sexual maturation study result where * indicates average gene 
expression profile of transcripts only induced in sexually mature female schistosomes 
obtained from bi-sex infection experiments.  (III) An example of one planned developmental 
expression profiling result where * indicates average gene expression of transcripts highly 
induced in 3 day through 7 day schistosomula. IE – immature egg, ME – mature egg, M – 
miracidia, MS – mother sporocyst, DS, daughter sporocyst, C – cercaria, 24HS – 24 hr 
schistosomula, 3DS – 3 day schistosomula, 7DS – 7 day schistosomula, 3WW – 3 week 
sexually immature worms, 7WW – 7 week sexually mature worms. (IV) Scatterplot of gene 
expression ratios obtained from 2 schistosome strains capable of inducing diverse 
immunopathology; * indicates those genes associated with the more virulent strain of parasite.   
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5. WHAT’S NEXT AND EXCITING FUTURE 
PROSPECTS  
Based on the above-described studies, we are excited about this 
technology’s impact on future parasitological investigations.  We plan on 
using parasite DNA microarrays to 1) continue studies into the sexual 
biology and developmental maturation of schistosomes, 2) investigate 
whether parasite gene expression profiles can be predictive of virulence 
and/or immuno-pathology, and 3) identify potential new immuno-
prophylactic or chemotherapeutic targets.  In addition to these investigations 
using parasite DNA microarrays, we also are currently using both human 
and murine DNA microarrays to study immune response induction and 
regulation during praziquantel chemotherapy of infected hosts.  
Transcriptional results obtained from these studies, in combination with co-
acquired immunological and parasitological data, will shed light into the 
mechanisms associating with host resistance, susceptibility, and the 
generation of a dominant and controlled type-2 response.  The interpretation 
of data collected from both parasite and host DNA microarray studies will be 
instrumental in developing new hypotheses that aid in the characterization of 
complex, infection-associated, biological interactions. 
6. FUTURE USE OF SCHISTOSOME DNA 
MICROARRAYS 
The goals of our future sex-associated studies are to use the above-
described schistosome DNA microarrays to identify: 1) genes transcribed in 
sexually mature adult male and female parasites, 2) genes longitudinally 
transcribed during sexual development and maturation, and 3) genes 
differentially regulated in murine infections initiated by single sex versus 
dual-sex parasite inoculums.  In addition to expanding the list of transcripts 
that associate with adult S. mansoni males and females, we plan on 
identifying adult gender-associated gene products from S. japonicum worms, 
where even less is known about its sexual maturation and egg biology.  We 
therefore hope to contribute to the identification of sex-associated gene 
transcripts in both species of schistosome.   
Although bimodal (adult male versus female) experiments will lead to the 
cataloguing of many additional adult gender-associated transcripts, we are 
equally interested in identifying those genes that are longitudinally regulated 
from immature through mature forms of these dioescious parasites.  The 
timing of gene expression will provide important clues into the development 
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of sexual maturity, conjugal biology, oviposition, and host/parasite 
interactions (12).  Gene transcripts that demonstrate female associations in 
the bimodal experiment described above can be additionally segregated into 
those that are temporally expressed before and after egg development.  
Therefore, male and female gene expression profiles will be obtained from 
worms harvested from infected murine hosts at progressive weeks post-
infection and probed across the DNA microarrays.  These experiments will 
help elucidate the transcriptional events associated with the acquisition of 
schistosome sexual maturity.  
Although it is envisioned that sex-associated transcription kinetics will be 
characterized in the above experiments, a third biological area to be 
addressed during our studies of schistosome sexual biology will involve 
identifying those genes differentially regulated in single -sex (hosts only 
infected with one parasite gender) versus dual-sex (hosts infected with both 
parasite genders) murine infections (*, Fig. 1, panel II).  It has been shown 
that female parasites depend upon direct interaction with male schistosomes 
to mature into a highly proficient egg-laying organism (13).  Conversely, the 
male schistosome seems capable of normal sexual development in the 
absence of the female, but some studies suggest that antigenic and 
biochemical changes do occur (14, 15).  In both cases, the genetic machinery 
affected by maturing in the absence of the opposite sex has yet to be 
thoroughly dissected.  To address this important subject, female and male 
parasites from single sex infections of each (16) will be harvested from 
murine hosts at progressive weeks post-infection.  The longitudinal pattern 
of gene expression will be assessed from each separate sex pool of RNA and 
then compared to those pools of separate sex RNA harvested from a dual sex 
murine infection via a common reference.  It is anticipated that these 
experiments will uncover contributions of previously unappreciated 
mechanisms involved in schistosome sexual maturation pathways, which 
depend upon gender interactions.   
 To complement these studies of schistosome sexual biology, we plan to 
use the S. mansoni DNA microarrays to profile gene expression across the 
parasite’s lifecycle and identify gene products associated with different 
parasite strains.  The goal of lifecycle expression profiling is to identify 
coordinated clusters of gene transcripts that associate with each particular 
life-stage.  Using this approach, we will be able to characterize the 
developmental biology of this pathogen to a large degree, which ultimately 
will identify transcripts involved in housekeeping functions, uniquely 
utilized metabolic pathways, infection of intermediate and definitive hosts, 
and modulation of protective immune mechanisms (Fig. 1, panel III).  
Further detailed elucidation of these genes’ functions may provide insight 
into novel strategies for immunological or drug intervention.   
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Finally, we plan to use both S. mansoni and S. japonicum DNA 
microarrays as tools to profile gene transcription differences and similarities 
among various collected field isolates (strains) and laboratory adapted 
parasite strains.  Information obtained from these investigations, in 
association with other field- and laboratory- collected parameters, may 
provide significant information related to the virulence of the profiled 
parasite strains useful in interpreting complicated immuno-epidemiological 
associations (*, Fig. 1, panel IV).  Taken together, data accumulated from 
our future use of schistosome DNA microarrays will provide novel, testable 
hypotheses related to diverse biological processes concerning host-parasite 
interactions, developmental biology, virulence, and sexual maturation of 
these pathogenic organisms.  
7. FUTURE USE OF HUMAN AND MOUSE DNA 
MICROARRAYS 
Investigations using host specific DNA microarrays are also currently 
being used in our laboratory to study immune response regulation during 
chemotherapeutic treatment.  Because any vaccine administered to a human 
population will likely be preceded by chemotherapeutic clearance of an 
active infection, understanding the effect of drug therapy on the host’s 
immune system is an important issue to investigate and will ultimately 
contribute to the development of an effective immunoprophylactic treatment.  
The present drug of choice for treatment of all human schistosomes is 
praziquantel.  While the exact mode of action of praziquantel is still not 
clear, experimental mouse studies (17-19) supported by human 
investigations (20), suggest that praziquantel therapy induces a protective 
immune response.  However, according to human re-infection studies, this 
protective immune response may not be long-lived in many individuals (eg. 
children have increased risk of becoming re-infected) (21, 22).  
Consequently, characterization of the immunological mechanisms induced 
by praziquantel treatment that contribute to worm elimination should be 
more carefully and thoroughly examined.  A study of this type would not 
only provide information critical to schistosome vaccinologists, but would 
also furnish the immunologist with insights into how the immune system 
regulates a potentially deleterious response against thousands of parasite 
antigens that are simultaneously released into the blood at the time of 
chemotherapy.       
Studies to date dissecting the human immune responses longitudinally 
after praziquantel treatment have been limited.  Most have examined the 
effect of chemotherapy on some aspect of the host immune system (using 
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sera, PBMCs, or whole blood assays) at periods of several weeks (20, 23) , 
months (22, 24, 25) , or years (21, 25) after treatment.  Although the majority 
of these studies have revealed the up-regulation of IgE and IgG responses as 
well as increased eosinophilia after praziquantel treatment, all of them have 
neglected to examine the early events induced immediately following 
chemotherapy.  Speculatively, these early host immuno-biological responses 
to dying worms could directly influence the magnitude of later events 
including the development of heightened antibody titers, proliferation of 
eosinophils, and ultimately, generation of immunity to a subsequent 
infection.   
Our current studies involve examining the host’s transcriptional profile 
longitudinally during praziquantel treatment, focusing on immediate as well 
as late time-points (Fig. 2).  In the murine studies, where careful control of 
the experimental procedure can be achieved, we are currently examining 
splenic, bonemarrow, and mesenteric lymph node expression profiles during 
praziquantel treatment in both infected as well as uninfected animals.  A 
DNA microarray consisting of 7445 unique elements (~33% of the predicted 
ORF content of the genome) will be utilized for these studies in the mouse 
(Fig. 2 panel III).  Our human studies focus on a well-characterized cohort of 
individuals living on Lake Albert in Uganda, Africa.  Adults living in this 
area are all infected with S. mansoni and have previously been shown to 
homogenously mount a rapid and vigorous immune response against parasite 
antigens following chemotherapy.  Because of a high infection rate and rapid 
post-treatment immune response, these indiv iduals provide a unique 
opportunity to thoroughly characterize the extent, quality, and magnitude of 
gene activity induced or repressed by chemotherapy and dissect how these 
differentially regulated genes influence the development of later 
immunological events (*, Fig. 2, panel II).  Here, we are using a DNA 
microarray (Fig. 2, panel I) consisting of 10560 unique elements (~33% of 
the predicted ORF content of the genome) and are specifically focusing on 
gene expression profiles obtained from whole blood (where the red blood 
cell component has been effectively removed).  The contribution of 
information collected from both murine and human experiments via DNA 
microarray analysis of selected tissues, in combination with classical 
immunological and parasitological studies, will help build a more robust 
picture of the immunological cascade triggered by praziquantel treatment of 
infected and uninfected individuals.  This information should prove useful 
towards our advanced understanding of praziquantel’s protective mechanism 
of action as well as provide important clues to the gene products that may be 
associated with resistance to re-infection; both topics remain a priority 
among planned future immunological investigations. 
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Figure 7-2. Host specific DNA microarrays (H. sapiens oligonucleotide DNA microarrays 
containing 10560 unique DNA elements (I) and M. musculus oligonucleotide DNA 
microarrays containing 7445 unique DNA elements (III)) will be used as a tool to identify 
patterns of gene expression differentially regulated upon praziquantel clearance of an active 
schistosome infection.  (II) K-means supervised clustering method used to segregate gene 
expression profiles differentially regulated during praziquantel treatment of schistosome-
infected hosts. * Indicates genes induced early after praziquantel treatment and ? indicates 
genes induced later after drug therapy (possible effector or regulatory transcripts). Other 
patterns of gene expression influenced by drug therapy can be visualized in the additional 
clusters. 
8. CONCLUDING REMARKS 
Although gene expression results obtained through the use of DNA 
microarrays will undoubtedly increase the path and scope of many future 
parasite/host investigations, there is still an obvious need to maintain the use 
of traditional experimental techniques in this functional genomics age.  How 
else would the gene products identified by DNA microarray investigations 
be further studied in the laboratory setting if we do not plan on using this 
wealth of information for testing hypotheses by current immunological, 
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biochemical, and molecular biological techniques?  In addition to classical 
techniques, new methodologies can be used to manipulate parasite and host 
gene expression.  Transgenic or gene deficient cell lines or animals are well 
established and RNAi and transient/stable transfection of parasites and host 
cells are being developed which collectively allow for the functional 
importance of selected gene products to be determined directly. 
Each investigator considering the use of DNA microarrays will 
additionally face the rewarding task of sifting through huge amounts of gene 
expression information to tease apart biologically significant relationships.  
The evolution of new bioinformatic approaches for DNA microarray data 
analysis will dramatically increase the speed in which these biological 
relationships are identified as well as provide novel opportunities for 
developing collaborative relationships between the biologist and the 
mathematician.  In terms of future research on schistosomiasis, DNA 
microarrays and other functional genomic tools have the profound potential 
to positively impact all areas, provided widespread use is routinely adopted 
alongside our traditional immuno-parasitological methodologies. 
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